Chunmin Liang

Dr. Chunmin Liang


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 March 2010 in Journal of Cancer Research and Clinical Oncology
Verified
Journal Article
Closed access
PDF file
ZSZhengbin Shen
Zhengbin Shen
SZShuang Zhou
Shuang Zhou
YWYanna Wang
Yanna Wang
RLRi-Lun Li
Ri-Lun Li
CZCuiping Zhong
Cuiping Zhong
YSYihong Sun
Yihong Sun

22 October 2019 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
MZMengxuan Zhu
Mengxuan Zhu
WXWeiyue Xu
Weiyue Xu
CWChuanyuan Wei
Chuanyuan Wei
JHJing Huang
Jing Huang
JXJietian Xu
Jietian Xu
CLChunmin Liang
Chunmin Liang
CCL14 is a member of CC chemokines and its role in hepatocellular carcinoma (HCC) is still unknown. In this study, CCL14 expression were analyzed by tissue microarray (TMA) including 171 paired tumor and peritumor tissues of patients from Zhongshan Hospital of Fudan University. We found for the first time that CCL14 was downregulated in HCC tumor tissues compared with peritumor tissues (P = 0.01). Meanwhile, CCL14 low expression in HCC tumor tissues is associated with a poor prognosis (P = 0.035). CCL14 also displayed its predictive value in high differentiation (P = 0.026), liver cirrhosis (P = 0.003), and no tumor capsule (P = 0.024) subgroups. The underlying mechanisms were further investigated in HCC cell lines by CCL14 overexpression and knock-down in vitro. We found overexpression of CCL14 suppressed proliferation and promoted apoptosis of HCC cells. Finally, the effect was confirmed by animal xenograft tumor models in vivo. The results shown overexpression of CCL14 lead to inhibiting the growth of tumor in nude mice. Interestingly, our data also implied that CCL14 played these effects by inhibiting the activation of Wnt/β-catenin pathway. These findings suggest CCL14 is a novel prognostic factor of HCC and serve as a tumor suppressor.

1 January 2016 in World Journal of Gastroenterology
Verified
Journal Article
Open access
HMHui-Ying Ma
Hui-Ying Ma
XLXin-Zhou Liu
Xin-Zhou Liu
CLChunmin Liang
Chunmin Liang
Gastric cancer (GC) is the fifth most common malignancy in the world. The major cause of GC is chronic infection with Helicobacter pylori (H. pylori). Infection with H. pylori leads to an active inflammatory microenvironment that is maintained by immune cells such as T cells, macrophages, natural killer cells, among other cells. Immune cell dysfunction allows the initiation and accumulation of mutations in GC cells, inducing aberrant proliferation and protection from apoptosis. Meanwhile, immune cells can secrete certain signals, including cytokines, and chemokines, to alter intracellular signaling pathways in GC cells. Thus, GC cells obtain the ability to metastasize to lymph nodes by undergoing the epithelial-mesenchymal transition (EMT), whereby epithelial cells lose their epithelial attributes and acquire a mesenchymal cell phenotype. Metastasis is a leading cause of death for GC patients, and the involved mechanisms are still under investigation. In this review, we summarize the current research on how the inflammatory environment affects GC initiation and metastasis via EMT.

6 July 2015 in Oncotarget
Verified
Journal Article
Open access
PDF file
HMHuiying Ma
Huiying Ma
LGLingling Gao
Lingling Gao
SLShichao Li
Shichao Li
JQJie Qin
Jie Qin
LCLong Chen
Long Chen
CLChunmin Liang
Chunmin Liang
CCR7 enhances TGF-1-induced epithelial-mesenchymal transition and is associated with lymph node metastasis and poor overall survival in gastric cancer CCR7 enhances TGF-β1-induced epithelial-mesenchymal transition and is associated with lymph node metastasis and poor overall survival in gastric cancer

3 September 2021 in Frontiers in Immunology
Verified
Journal Article
Open access
JHJing Huang
Jing Huang
PSPeiwen Song
Peiwen Song
KHKaibin Hang
Kaibin Hang
ZCZeka Chen
Zeka Chen
ZZZidan Zhu
Zidan Zhu
CLChunmin Liang
Chunmin Liang
Sleep disturbance is common in patients with cancer and is associated with poor prognosis. However, the effects of sleep deprivation (SD) on immune surveillance during the development of hepatocellular carcinoma (HC) and the underlying mechanisms are not known. This was investigated in the present study using mouse models of SD and tumorigenesis. We determined that acute and chronic sleep deprivation (CSD) altered the relative proportions of various immune cell types in blood and peripheral organs. CSD increased tumor volume and weight, an effect that was enhanced with increasing CSD time. Expression of the cell proliferation marker Ki-67 was elevated in tumor tissues, and tumor cell infiltration into adjacent muscles was enhanced by CSD. Multicolor flow cytometry analysis revealed that CSD significantly reduced the numbers of antitumor CD3+ T cells and natural killer (NK) cells and increased that of immunosuppressive CD11b+ cells infiltrating into the tumor microenvironment from the spleen via the peripheral blood. These results indicate that CSD impairs immune surveillance mechanisms and promotes immunosuppression in the tumor microenvironment to accelerate tumor growth, underscoring the importance of alleviating sleep disturbance in HC patients in order to prevent HC progression.

1 January 2015 in World Journal of Hepatology
Verified
Journal Article
Open access
CLChunmin Liang
Chunmin Liang
LCLong Chen
Long Chen
HHHeng Hu
Heng Hu
HMHui-Ying Ma
Hui-Ying Ma
LGLing-Ling Gao
Ling-Ling Gao
CZCui-Ping Zhong
Cui-Ping Zhong
The chemokine system consists of four different subclasses with over 50 chemokines and 19 receptors. Their functions in the immune system have been well elucidated and research during the last decades unveils their new roles in hepatocellular carcinoma (HCC). The chemokines and their receptors in the microenvironment influence the development of HCC by several aspects including: inflammation, effects on immune cells, angiogenesis, and direct effects on HCC cells. Regarding these aspects, pre-clinical research by targeting the chemokine system has yielded promising data, and these findings bring us new clues in the chemokine-based therapies for HCC.